m (typing error.) |
|||
Line 707: | Line 707: | ||
post:"ADVISOR", | post:"ADVISOR", | ||
msjor:"Pharmaceutical Administration", | msjor:"Pharmaceutical Administration", | ||
− | declaration:"Too rich to | + | declaration:"Too rich to introduce." |
}, | }, | ||
{ | { |
Revision as of 07:27, 21 October 2021
![](https://static.igem.org/mediawiki/2021/c/c4/T--CPU_CHINA--loading.gif)
![](https://static.igem.org/mediawiki/2021/a/a5/T--CPU_CHINA--members--Top.png)
PORTRAIT
- {{item.lab}}
- {{item.lab}}
{{name}}
{{post}}
{{major}}
{{declaration}}
![](https://static.igem.org/mediawiki/2021/8/84/T--CPU_CHINA--members--Drug1.png)
![](https://static.igem.org/mediawiki/2021/1/16/T--CPU_CHINA--members--Drug2.png)
{{ item.name }}
{{ item.post }}
{{ item.major }}
{{ item.declaration }}